Skip to content

The effectiveness of Maizhijieyou Decoction in treating subthreshold depression: a double-blind randomized placebo-controlled study

The effectiveness of Maizhijieyou Decoction in treating subthreshold depression: a double-blind randomized placebo-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000260
Enrollment
Unknown
Registered
2025-02-13
Start date
2025-02-20
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subthreshold depression

Interventions

Experimental group:Maizhijieyou decoction
control group:Maizhijieyou decoction placebo

Sponsors

Dongfang Hospital of Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria of subthreshold depression; 2) Men and women aged 18 years and above; 3) signed the informed consent. Only those who met the above three criteria were included in the study.

Exclusion criteria

Exclusion criteria: 1) met the DSM-5 criteria for depression; 2) specialists' assessment of factors inappropriate for trial participation (e.g. recent evidence of self-harm current suicidal self-harm) Thoughts or behaviors significant cognitive impairment); 3) Bipolar disorder or psychotic disorder; 4) Currently participating in other clinical studies; 5) known history of alcohol and drug abuse; 6) patients with severe organic diseases severe liver or renal dysfunction severe arrhythmia or cardiac insufficiency; 7) Pregnant breastfeeding and planning pregnancy. Any of the above conditions shall be excluded.

Design outcomes

Primary

MeasureTime frame
scores of Patient Health Questionnaire-9 (PHQ-9);

Secondary

MeasureTime frame
scores of traditional Chinese medicine depression syndrome Scale;Blood urea nitrogen;scores of generalized anxiety disorder-7 scale (GAD-7);Serum creatinine;Electrocardiogram;Aspartate aminotransferase (AST);Blood routine test;scores of 12-item short form health survey (SF-12);Urine routine test;Alanine aminotransferase (ALT);

Countries

China

Contacts

Public ContactZhenyun Han

Dongfang Hospital of Beijing University of Chinese Medicine

tohanzhenyun@sina.com13581647676

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026